ImageneBio, Inc. (IMA) — Strategic Asset Allocation Index
ImageneBio, Inc. (IMA) has a Strategic Asset Allocation Index of 0.0% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $133.14 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
ImageneBio, Inc. Strategic Asset Allocation Index (2023–2025)
This chart shows how ImageneBio, Inc.'s Strategic Asset Allocation Index has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $133.14 Million USD. Explore cash flow conversion of ImageneBio, Inc. to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for ImageneBio, Inc. (2023–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for ImageneBio, Inc. from 2023 to 2025, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see IMA company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.0% | $0.00 | $- | $0.00 | $133.14 Million | ▼ -0.7 pp |
| 2024 | 0.7% | $942.00K | $- | $942.00K | $125.93 Million | ▲ +0.2 pp |
| 2023 | 0.6% | $942.00K | $- | $942.00K | $169.76 Million | — |